- Shop Products
- Services & Tools
- Business Resources
- Clinical Resources
- About Us
- Contact Us
As you map out your plan for patient care moving forward, from patient prioritization and new patient workflows to telehealth and immunizations, be sure to:
“Over the last decade, the vaccine landscape has evolved to encompass a growing adult immunization platform, yet a recent study from Avalere Health found that Medicare spent $106 billion on vaccine-preventable disease costs from 2016 to 2018.”1
The CDC’s latest standards for immunization practices are clear: routine vaccination is an essential preventive care service for children, adolescents and adults (including pregnant women) that should not be delayed because of the COVID-19 pandemic.2 Both the CDC and the American Academy of Pediatrics (AAP) recommend that children continue to receive routine vaccinations during the COVID-19 pandemic.
Our returnability program for expired vaccines lets you confidently order what you need and return expired vaccines, if necessary.
See our vaccine portfolios for children and adults
While fewer cases of COVID-19 have been reported in children to date, cases have been steadily increasing and children still account for a large part of the population.3 These resources can help you protect your youngest patients.
6 in 10 adults in the US have chronic disease4 and COVID-19 has put these patients even more at risk.
As you reopen and reconnect with these patients, keep us in mind for your specialty needs. We distribute more pharmaceutical products to alternative care settings than any other distributor, with reliable distribution, smart solutions and a team of experts to help you along the way.
Our growing portfolio of pharmaceuticals can help support the diverse needs of your practice and patient population – especially when it comes to managing chronic care conditions.
How are you preparing for flu each season? Let McKesson FluWise® help you get ready for flu, with our comprehensive program giving you access to a variety of professional flu products, savings and stability, and support every step of the way. Learn more about McKesson FluWise and how we can help.
Research on post-COVID-19 patients shows that in some cases, the road to recovery can be long and complicated by other healthcare concerns. Lack of oxygen and widespread inflammation due to COVID-19 can damage the heart, kidneys, liver, brain and other organs, and can also lead to risk of future illnesses such as acute respiratory distress syndrome (ARDS), heart conditions, stroke, kidney disease and pneumonia.5
A study of post-SARs patients shows that COVID-19 patients could be at risk of:6
In order to help you better understand these implications for your patients both now and in the future, we’ve compiled educational resources to support you as you treat patients in COVID-19 recovery.
Research update: COVID-19 clinical activity trends (athenahealth®)
Trends in healthcare (athenahealth®)
Practicing during a pandemic (athenahealth®)
Respiratory hygiene & cough etiquette (MedTrainer)
One of the most important decisions you’ll make while preparing to see patients again is whether to have in-office visits, offer telehealth services, or a combination of both. Here are some resources to help you decide and implement.
Telehealth helps you continue seeing patients while limiting the risk of exposure to infectious disease for both your patients and staff, as well as expanding your reach to communities with limited access to healthcare services.
A recent poll shows that 75% of patients want to return to their doctor’s office after remaining home during the COVID-19 pandemic,7 so it’s important to let your patients know when you’re re-opening.
Check out this patient engagement toolkit from Medtronic, offering resources from digital banner downloads to a patient letter and email template so you can create trust and reassure patients they can seek care safely at your practice.
*Next-day delivery available for 95% of customers.
7: National poll by AdvaMed, AORN, AHA 5.20.20
All trademarks and registered trademarks are the property of their respective owners.
Be advised that information contained herein is intended to serve as a useful reference for informational purposes only and is not complete clinical information. This information is intended for use only by competent healthcare professionals exercising judgment in providing care. McKesson cannot be held responsible for the continued currency of or for any errors or omissions in the information.